#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13758	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2079	657.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	853	C,T	759,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13758	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2079	657.8	0	HET	.	.	.	C611T	.	611	611	C	832	832	C	826	C,T	414,327	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24710	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3452	712.9	0	.	n	.	0	T695C	SNP	695	695	T	926	926	C	776	C,T	694,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24710	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3452	712.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2202	2202	C	773	C,T	531,155	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24710	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3452	712.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2828	2828	T	735	T,C	325,357	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24710	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3452	712.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2276	2276	A	730	A	671	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24710	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3452	712.9	0	HET	.	.	.	G1337A	.	1337	1337	G	1568	1568	G	860	G,A	542,229	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2014	folP	852	852	100.0	folP.l6.c17.ctg.1	1437	139.3	1	SNP	p	R228S	1	.	.	682	684	AGC	952	954	AGC	192;193;194	A;G;C,T	172;174;174,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	165.2	1	SNP	p	S91F	0	.	.	271	273	TCC	585	587	TCC	182;179;179	T;C;C	168;165;165	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	165.2	1	SNP	p	D95G	0	.	.	283	285	GAC	597	599	GAC	186;188;188	G;A;C	168;170;168	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	165.2	1	SNP	p	D95N	0	.	.	283	285	GAC	597	599	GAC	186;188;188	G;A;C	168;170;168	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1550	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1247	123.1	1	SNP	p	G45D	1	.	.	133	135	GAC	504	506	GAC	198;199;202	G;A;C	182;181;182	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	802	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	886	89.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5048	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2966	169.6	1	SNP	p	D86N	0	.	.	256	258	GAC	524	526	GAC	203;209;212	G;A;C	190;193;198	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5048	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2966	169.6	1	SNP	p	S87W	0	.	.	259	261	AGT	527	529	AGT	213;210;213	A;G;T	199;195;194	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5048	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2966	169.6	1	SNP	p	S87I	0	.	.	259	261	AGT	527	529	AGT	213;210;213	A;G;T	199;195;194	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5048	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2966	169.6	1	SNP	p	S87R	0	.	.	259	261	AGT	527	529	AGT	213;210;213	A;G;T	199;195;194	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5048	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2966	169.6	1	SNP	p	S88P	0	.	.	262	264	TCC	530	532	TCC	213;216;221	T;C;C	196;199;203	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4328	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2627	164.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1447	1449	GGC	201;199;199	G;G;C	186;182;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1215	1217	GCA	223;223;224	G;C;A	198;200;201	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1218	1220	ATC	226;226;229	A;T;C	200;198;201	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1230	1232	GTG	224;223;223	G;T;G	203;199;202	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1230	1232	GTG	224;223;223	G;T;G	203;199;202	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1734	1736	ACC	201;202;203	A;C;C	175;177;181	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1788	1790	GCG	199;199;198	G;C;G,T	174;165;167,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1788	1790	GCG	199;199;198	G;C;G,T	174;165;167,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1911	1913	GGC	168;170;170	G;G;C	153;150;154	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1920	1922	GGC	161;157;155	G;G;C	143;136;134	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3840	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2267	168.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1938	1940	CCG	146;145;146	C,G;C;G,T	104,10;107;108,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5388	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3038	176.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1604	1606	CTG	215;214;216	C;T;G	181;182;180	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2396	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1656	143.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	465	465	C	186	C	165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	544	546	GTT	224;225;226	G;T;T	199;197;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	N121S	NONSYN	361	363	AAC	772	774	AGC	200;200;201	A;G,T;C	180;182,1;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	775	777	AAA	202;202;204	A;A;A	185;188;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	838	840	GAA	210;211;211	G;A;A,G	185;185;181,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	862	864	GCA	215;216;219	G;C;A	185;187;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	K207_M208insK	INS	619	619	A	1030	1030	A	214	A	192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1048	1050	TCA	206;213;214	T;C;A	198;204;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2508	porB1b	1038	1038	97.23	porB1b.l15.c4.ctg.1	1600	156.1	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1165	1165	T	173	T	158	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9738	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4927	197.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2087	2089	AAT	225;220;221	A;A;T	196;192;190	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	998	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	981	100.8	1	SNP	p	V57M	1	.	.	169	171	ATG	537	539	ATG	211;211;210	A;T;G	192;191;190	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
